Safety and effectiveness of lopinavir/ritonavir twice-daily in cART naïve patients with HIV-1 infection: Data from POLCA Study Group

Conclusion In POLCA cohort 24 months treatment with LPV/r-based regimen was safe and effective. Gastrointestinal side effects and lipids disorders were quite common but rarely led to treatment discontinuation.
Source: HIV and AIDS Review - Category: Infectious Diseases Source Type: research